In intention-to-treat analysis, screening with VIA resulted in a 31% reduction in the cervical cancer–specific death rates (11.1 vs. 16.2 deaths per 100,000; mortality rate ratio, 0.69, P = .003).
Screened women also had a 7% reduction in overall mortality stemming from earlier diagnosis, although this difference was not statistically significant.
Dr. Shastri disclosed no relevant conflicts of interest. Dr. Badwe disclosed no relevant conflicts of interest.